Detalhe da pesquisa
1.
Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells.
Br J Cancer
; 130(8): 1402-1413, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38467828
2.
Enhanced thrombin generation detected with ST-Genesia analyzer in patients with newly diagnosed multiple myeloma.
J Thromb Thrombolysis
; 55(3): 464-473, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36630029
3.
Identification of seasonal variation in the diagnosis of acute myeloid leukaemia: a population-based study.
Br J Haematol
; 198(3): 545-555, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35639095
4.
Correction: Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells.
Br J Cancer
; 130(8): 1414, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38575733
5.
Cytoplasmic localization of wild-type survivin is associated with constitutive activation of the PI3K/Akt signaling pathway and represents a favorable prognostic factor in patients with acute myeloid leukemia.
Haematologica
; 98(12): 1877-85, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23812937
6.
Clonal genetic evolution at relapse of favorable-risk acute myeloid leukemia with NPM1 mutation is associated with phenotypic changes and worse outcomes.
Haematologica
; 103(9): e400-e403, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29622659
7.
Identifying prognostic gene panels in acute myeloid leukemia.
Expert Rev Hematol
; 16(4): 277-287, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36951195
8.
Evolving Risk Classifications in AML in a Real-Life Scenario: After Changes upon Changes, Is It More and More Adverse?
Cancers (Basel)
; 15(5)2023 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36900222
9.
Large-scale production of superparamagnetic iron oxide nanoparticles by flame spray pyrolysis: In vitro biological evaluation for biomedical applications.
J Colloid Interface Sci
; 650(Pt A): 560-572, 2023 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37429163
10.
Understanding the Notch Signaling Pathway in Acute Myeloid Leukemia Stem Cells: From Hematopoiesis to Neoplasia.
Cancers (Basel)
; 14(6)2022 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35326610
11.
An integrated prognostic model for diffuse large B-cell lymphoma treated with immunochemotherapy.
EJHaem
; 3(3): 722-733, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36051055
12.
No Evidence that CD33 rs12459419 Polymorphism Predicts Gemtuzumab Ozogamicin Response in Consolidation Treatment of Acute Myeloid Leukemia Patients: Experience of the PETHEMA Group.
Dis Markers
; 2022: 3132941, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36051360
13.
High-throughput RNA sequencing transcriptome analysis of ABC-DLBCL reveals several tumor evasion strategies.
Leuk Lymphoma
; 63(8): 1861-1870, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35379068
14.
Nonleukemic myeloid dendritic cells obtained from autologous stem cell products elicit antileukemia responses in patients with acute myeloid leukemia.
Transfusion
; 51(7): 1546-55, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21303373
15.
Inflammaging, an Imbalanced Immune Response That Needs to Be Restored for Cancer Prevention and Treatment in the Elderly.
Cells
; 10(10)2021 09 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34685542
16.
Understanding the Hedgehog Signaling Pathway in Acute Myeloid Leukemia Stem Cells: A Necessary Step toward a Cure.
Biology (Basel)
; 10(4)2021 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33804919
17.
A Multidisciplinary Journey towards Bone Tissue Engineering.
Materials (Basel)
; 14(17)2021 Aug 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34500986
18.
Inflammation rapidly recruits mammalian GMP and MDP from bone marrow into regional lymphatics.
Elife
; 102021 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33830019
19.
Development and validation of a predictive model of in-hospital mortality in COVID-19 patients.
PLoS One
; 16(3): e0247676, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33661939
20.
Tumor necrosis factor-α-secreting CD16+ antigen presenting cells are effectively removed by granulocytapheresis in ulcerative colitis patients.
J Gastroenterol Hepatol
; 25(12): 1869-75, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21091999